acetylcysteine has been researched along with epirubicin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Sahoo, RK; Sharma, A | 1 |
Bando, A; Egashira, N; Imuta, M; Nishime, Y; Oishi, R; Tonogai, Y; Yamada, T; Yano, T | 1 |
Ala, U; Brusa, D; Calautti, E; Magnuson, MA; Neri, F; Oliviero, S; Provero, P; Riganti, C; Saoncella, S; Tassone, B | 1 |
1 review(s) available for acetylcysteine and epirubicin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for acetylcysteine and epirubicin
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Sinusoidal obstruction syndrome during induction therapy for acute lymphoblastic leukemia managed with N-acetyl Cysteine.
Topics: Acetylcysteine; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Dexamethasone; Epirubicin; Female; Fibrinolytic Agents; Hepatic Veno-Occlusive Disease; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sepsis; Young Adult | 2011 |
Activation of p38 MAPK by oxidative stress underlying epirubicin-induced vascular endothelial cell injury.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cells, Cultured; Enzyme Activation; Epirubicin; Glutathione; In Situ Nick-End Labeling; Mitochondria; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Swine | 2012 |
Rictor/mTORC2 deficiency enhances keratinocyte stress tolerance via mitohormesis.
Topics: Acetylcysteine; Animals; Apoptosis; Cell Proliferation; Cells, Cultured; Cellular Senescence; Epirubicin; Glutamic Acid; Hyperplasia; Keratin-14; Keratinocytes; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitochondria; Radiation Tolerance; Rapamycin-Insensitive Companion of mTOR Protein; Reactive Oxygen Species; Skin; Tetradecanoylphorbol Acetate; Transcriptome; X-Rays | 2017 |